Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.
Show more...
執行長
Mr. Sanjay Prabhakar Murdeshwar
員工
81
國家
IN
ISIN
INE234A01025
上市
0 Comments
分享你的想法
FAQ
Novartis India 今天的股價是多少?▼
NOVARTIND.NSE 目前價格為 ₹674 INR,過去 24 小時下跌了 -2.66%。在圖表上更密切關注 Novartis India 股票的表現。
Novartis India 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Novartis India 的股票以代號 NOVARTIND.NSE 進行交易。